Literature DB >> 2956412

Repeated amphetamine pretreatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization.

J V Barnett, D S Segal, R Kuczenski.   

Abstract

The repeated daily administration of moderate doses of amphetamine results in an augmentation of the behavioral response to subsequent amphetamine challenge. One feature of the augmentation is a shift in the type of perseverative behaviors to those generally associated with higher acute doses of the drug. Consistent with these observations, rats pretreated with six daily injections of amphetamine (3 mg/kg) exhibited primarily oral stereotypies to a challenge dose of 2.5 mg/kg of amphetamine, whereas control animals exhibited focused sniffing and repetitive head movements. Previously we found that the acute administration of amphetamine or methylphenidate only at doses which induce oral stereotypies promotes a rapid desensitization of striatal dopamine-stimulated adenylate cyclase. We therefore examined the effects of repeated amphetamine pretreatment on this index of D1 dopamine receptors. The administration of 2.5 mg/kg of amphetamine produced a 2-fold shift to the right in the concentration-response curve for dopamine-stimulated adenylate cyclase in animals pretreated with amphetamine, but not in saline pretreated controls. No effect of the chronic amphetamine pretreatment on dopamine stimulated cyclase in the absence of amphetamine challenge was observed. The binding of [3H]cis-flupenthixol to striatal D1 dopamine receptors was not affected by acute or chronic amphetamine. These results suggest a relationship between stimulant-induced desensitization of striatal D1 dopamine receptors and the induction of oral stereotypies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2956412

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Prolonged exposure of rats to intravenous methamphetamine: behavioral and neurochemical characterization.

Authors:  David S Segal; Ronald Kuczenski; Meghan L O'Neil; William P Melega; Arthur K Cho
Journal:  Psychopharmacology (Berl)       Date:  2005-03-15       Impact factor: 4.530

2.  Comparative behavioral sensitization to stereotypy by direct and indirect dopamine agonists in CF-1 mice.

Authors:  J B Bedingfield; L D Calder; R Karler
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

3.  Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats.

Authors:  P E Paulson; T E Robinson
Journal:  Synapse       Date:  1995-01       Impact factor: 2.562

4.  Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain.

Authors:  Abesh K Bhattacharjee; Lisa Chang; Mei Chen; Laura White; Jane M Bell; Richard P Bazinet; Stanley I Rapoport
Journal:  Int J Neuropsychopharmacol       Date:  2008-06-23       Impact factor: 5.176

5.  Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats.

Authors:  Cynthia A Crawford; Michael T Williams; Jodie L Kohutek; Fiona Y Choi; Shelly T Yoshida; Sanders A McDougall; Charles V Vorhees
Journal:  Brain Res       Date:  2006-02-14       Impact factor: 3.252

Review 6.  Therapeutic potential of ectopic olfactory and taste receptors.

Authors:  Sung-Joon Lee; Inge Depoortere; Hanns Hatt
Journal:  Nat Rev Drug Discov       Date:  2019-02       Impact factor: 84.694

7.  Caenorhabditis elegans as an in vivo Model to Assess Amphetamine Tolerance.

Authors:  Dayana Torres Valladares; Sirisha Kudumala; Murad Hossain; Lucia Carvelli
Journal:  Brain Behav Evol       Date:  2021-04-08       Impact factor: 1.808

8.  Methamphetamine induces endoplasmic reticulum stress related gene CHOP/Gadd153/ddit3 in dopaminergic cells.

Authors:  Yasuyuki Irie; Makio Saeki; Hidekazu Tanaka; Yonehiro Kanemura; Shinpei Otake; Yoshiyuki Ozono; Toshisaburou Nagai; Yukiko Kondo; Kenzo Kudo; Yoshinori Kamisaki; Naomasa Miki; Eiichi Taira
Journal:  Cell Tissue Res       Date:  2011-07-26       Impact factor: 5.249

9.  Mitigation of indomethacin-induced gastrointestinal damages in fat-1 transgenic mice via gate-keeper action of ω-3-polyunsaturated fatty acids.

Authors:  Young-Min Han; Jong-Min Park; Jing X Kang; Ji-Young Cha; Ho-Jae Lee; Migeyong Jeong; Eun-Jin Go; Ki Baik Hahm
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.